Could a sleep drug help smokers stay Smoke-Free?
NCT ID NCT07328594
First seen Jan 11, 2026 · Last updated May 20, 2026 · Updated 26 times
Summary
This study tests whether daridorexant, a recently approved insomnia medication, can improve sleep and daytime alertness in smokers who are trying to quit. Poor sleep is a major reason people relapse when quitting smoking. The study will involve 44 adult smokers who will take the drug and monitor their sleep and smoking habits for three weeks. The goal is to see if better sleep can make quitting easier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Legacy Research Institute
Portland, Oregon, 97232, United States
Conditions
Explore the condition pages connected to this study.